Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 8,881–8,900 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass III

Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 pledget applicators per jar, Rx only. Manufactured by Ei LLC 2865 N. Cannon Blvd. Kannapolis, NC 18083. NDC# 61748-0201-60

by Akorn, Inc.

Reason
Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities
Recall initiated
October 29, 2018
Reported by FDA
December 5, 2018
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Sandoz Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 1000-count bottles, Rx Only, Finished Drug Product Manufactured by: Lek Pharmaceuticals d.d. SI-1526 Ljubljana,Sovenia for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5207-10.

by Sandoz, Inc

Reason
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Recall initiated
November 1, 2018
Reported by FDA
December 5, 2018
Distribution
OH, PR

View recall →

Drug Recall Terminated Historical recordClass II

Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1

by Ascend Laboratories LLC

Reason
Presence of Foreign Substance; metal shard found in tablet
Recall initiated
November 14, 2018
Reported by FDA
December 5, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Germ Bloc Health Hand Sanitizer Foam (benzalkonium chloride 0.13%) 7.5fl.oz./222mL refill bags, AvKARE, Inc. Pulaski, TN 38478 www.avkare.com, NDC 5026835427, UPC 3 50268 35408

by AVKARE Inc.

Reason
Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product
Recall initiated
November 20, 2018
Reported by FDA
December 5, 2018
Distribution
WA only

View recall →

Drug Recall Terminated Historical recordClass III

Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, packaged in HDPE 60 cc bottles, Rx only, MFG: Sandoz Inc., Princeton, NJ, Repackaged by: RemedyRepack, Indiana, PA, Original NDC 00185-0122-01Repackaged NDC 70518-1087-00, 14 capsules in HDPE 60 cc bottles in cardboard trays & HDPE 60 cc bottles in plastic bags, Repackaged NDC 70518-1087-01, 10 capsules in HDPE 60 cc bottles in cardboard trays.

by RemedyRePack Inc.

Reason
Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).
Recall initiated
November 7, 2018
Reported by FDA
December 5, 2018
Distribution
Product was distributed to two medical facilities in Pennsylvania.

View recall →

Drug Recall Terminated Historical recordClass II

INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx only, packaged in 2 mL Sterile Single Dose Vial, Mfd by Patheon Italia S.p.A. Ferentino, Italy NDC 52544-931-07

by ALLERGAN

Reason
Failed Stability Specification: out of specification for iron content.
Recall initiated
November 8, 2018
Reported by FDA
December 5, 2018
Distribution
Product was distributed throughout the United States.

View recall →

Drug Recall Terminated Historical recordClass II

Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
Recall initiated
November 7, 2018
Reported by FDA
November 28, 2018
Distribution
U.S.A.nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Medi-Stat Foam, Antimicrobial Hand Soap, Chloroxylenol 0.5%, 1250 mL (42.3 fl oz), OTC, Ecolab, 370 Wabasha Street N, St. Paul, MN 55102, NDC 47593-503-59

by Ecolab Inc

Reason
Labeling: Label mix-up - the label on the product may not match the formula in the bottle.
Recall initiated
November 9, 2018
Reported by FDA
November 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Equi-Soft Foam, Antimicrobial Hand Soap, 0.55% Benzalkonium Chloride, 25 fl oz (750 mL), OTC, Ecolab, 370 Wabasha Street N, St. Paul, MN 55102, NDC 47593-521-41

by Ecolab Inc

Reason
Labeling: Label mix-up - the label on the product may not match the formula in the bottle.
Recall initiated
November 9, 2018
Reported by FDA
November 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100-count Unit Dose Blisters, Rx only, Amerisource Health Services DBA American Health Packaging, 2550-A John Glenn Avenue Columbus, OH 43217, NDC 68084-446-01 (Individual Dose NDC: 68064-446-11)

by American Health Packaging

Reason
Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that "These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation."
Recall initiated
November 9, 2018
Reported by FDA
November 28, 2018
Distribution
U.S.A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

GSMS Irbesartan Tablets, USP, 300 mg,(a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.

by Sciegen Pharmaceuticals Inc

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Recall initiated
October 29, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.

by Sciegen Pharmaceuticals Inc

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Recall initiated
October 29, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Marketed by: GSMS Incorporated Camarillo, CA 93012 USA, NDC 60429-640-90.

by Sciegen Pharmaceuticals Inc

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Recall initiated
October 29, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755. Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.

by Sciegen Pharmaceuticals Inc

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Recall initiated
October 29, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Westminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-120-01), (b) 90-count bottle (NDC 69367-120-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755, Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854, Made in the USA.

by Sciegen Pharmaceuticals Inc

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Recall initiated
October 29, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90-count bottle (NDC 69367-119-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc Hauppauge, NY 11755 Manufactured for Westminister Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA

by Sciegen Pharmaceuticals Inc

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.
Recall initiated
October 29, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Antacid Tablets, Calcium Carbonate chewable tablets, 750mg, 60-count bottle, OTC, [Healthy Accents brand NDC: 55316-014-72, Distributed by DZA Brands, LLC, Salisbury, NC 28147, Scarborough, ME 04074], [HealthMart Pharmacy brand NDC: 62011-0295-1, Distributed by McKessen, One Post Street, San Francisco, CA 94104], [DG health brand NDC: 55910-717-72, Distributed By Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37072]

by L. Perrigo Company

Reason
Presence of foreign substance: Product found to contain metal particles.
Recall initiated
November 6, 2018
Reported by FDA
November 28, 2018
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

IRBESARTAN Tablets, USP 300 mg (a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90) Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Distributed by: GSMS, Incorporated, Camarillo, CA 93012, USA.

by Golden State Medical Supply Inc.

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
Recall initiated
November 2, 2018
Reported by FDA
November 28, 2018
Distribution
Product was distributed throughout the United States.

View recall →

Drug Recall Terminated Historical recordClass II

IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90) Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Distributed by: GSMS, Incorporated, Camarillo, CA 93012, USA.

by Golden State Medical Supply Inc.

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
Recall initiated
November 2, 2018
Reported by FDA
November 28, 2018
Distribution
Product was distributed throughout the United States.

View recall →

Drug Recall Terminated Historical recordClass II

IRBESARTAN Tablets, USP 75 mg 90-count bottle, Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Distributed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-640-90.

by Golden State Medical Supply Inc.

Reason
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
Recall initiated
November 2, 2018
Reported by FDA
November 28, 2018
Distribution
Product was distributed throughout the United States.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.